PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16230416-2	2005	Gemcitabine is activated by dCyd kinase (dCK) and interferes, as its triphosphate dFdCTP, with tumor growth through incorporation into DNA.	triphosphoric acid	69-81	Calcium/calmodulin-dependent protein kinase II	Drosophila melanogaster	41-44	
18378536-2	2008	Gemcitabine is taken up into the cell via human nucleoside transporters (hNTs) and is intracellularly phosphorylated by deoxycytidine kinase (dCK) to its monophosphate and subsequently into its main active triphosphate metabolite 2",2"-difluorodeoxycytidine triphosphate (dFdCTP), which is incorporated into DNA and inhibits DNA synthesis.	triphosphoric acid	206-218	Calcium/calmodulin-dependent protein kinase II	Drosophila melanogaster	142-145	
3335008-8	1988	The decreased rate of accumulation of products of dCK in intact cells containing 110 microM ara-CTP suggests that this active triphosphate may limit its own synthesis and phosphorylation of other substrates.	triphosphoric acid	126-138	Calcium/calmodulin-dependent protein kinase II	Drosophila melanogaster	50-53	
12799644-1	2003	Gemcitabine (2",2"-difluorodeoxycytidine) is a deoxycytidine analogue that is activated by deoxycytidine kinase (dCK) to its monophosphate and subsequently to its triphosphate dFdCTP, which is incorporated into both RNA and DNA, leading to DNA damage.	triphosphoric acid	163-175	Calcium/calmodulin-dependent protein kinase II	Drosophila melanogaster	113-116	
26400223-1	2016	Deoxycytidine kinase (dCK) is a critical enzyme involved in intracellular phosphorylation of lamivudine (LAM) to its active triphosphates.	triphosphoric acid	124-137	Calcium/calmodulin-dependent protein kinase II	Drosophila melanogaster	22-25